Breaking News Instant updates and real-time market news.

KMF

Kayne Anderson Midstream/Energy Fund

$2.47 /

+0.295 (+13.59%)

08:32
03/23/20
03/23
08:32
03/23/20
08:32

Kayne Anderson Midstream/Energy Fund reports $135M on balance sheet

Kayne Anderson Midstream/Energy Fund announced an update on its balance sheet and leverage levels. The Fund has continued to take steps to increase its cash position. As of March 20, 2020, the Fund had $135 million of cash on its balance sheet, including cash it will receive Tuesday for securities it has recently sold. The Fund plans to prudently use its cash balance to reduce leverage levels over the next month in a way that minimizes prepayment penalties and maximizes shareholder value. Currently, the Fund has $157 million of unsecured senior notes and $75 million of mandatory redeemable preferred shares outstanding. It is the Fund's intention to comply with all applicable 1940 Act leverage tests as well as the covenants on its debt agreements and the terms of its preferred stock. As of March 20th, the Fund's asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 256% and the Fund's asset coverage ratio under the 1940 Act with respect to total leverage was 173%. The Fund is still in the process of determining what portion of its cash balance will be used to redeem debt and what portion will be used to redeem preferred stock. For illustrative purposes, assuming the Fund uses all of its cash to repay outstanding indebtedness, the pro forma coverage ratios are estimated to be 1041% for the '40 Act Debt Test and 266% for the '40 Act Leverage Test.

TODAY'S FREE FLY STORIES

Hot Stocks
General Cannabis announces multi-million strategic equity investment » 08:45
06/01/20
06/01
08:45
06/01/20
08:45
CANN

General Cannabis

$0.00 /

+ (+0.00%)

General Cannabis…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CANN General Cannabis
$0.00 /

+ (+0.00%)

CANN General Cannabis
$0.00 /

+ (+0.00%)

04/08/20 Raymond James
Ontario AG order positive for Canadian cannabis stocks, says Raymond James
11/05/19 BofA/Merrill
BofA says Mexico cannabis legalization 'still in play' in 2020 after extension
10/10/19 Stifel
Hexo miss further damages cannabis industry credibility, says Stifel
09/26/19 Compass Point
Cannabis banking bill should find path to passage in Senate, says Compass Point
CANN General Cannabis
$0.00 /

+ (+0.00%)

CANN General Cannabis
$0.00 /

+ (+0.00%)

Hot Stocks
Hancock Jaffe Laboratories announces intent to merge with Catheter Precision » 08:45
06/01/20
06/01
08:45
06/01/20
08:45
HJLI

Hancock Jaffe Laboratories

$0.33 /

-0.005 (-1.51%)

Hancock Jaffe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HJLI Hancock Jaffe Laboratories
$0.33 /

-0.005 (-1.51%)

HJLI Hancock Jaffe Laboratories
$0.33 /

-0.005 (-1.51%)

08/06/19 Maxim
Hancock Jaffe Laboratories initiated with a Buy at Maxim
08/06/19 Maxim
Hancock Jaffe Laboratories initiated with a Buy at Maxim
Options
Largest borrow rate increases among liquid names » 08:45
06/01/20
06/01
08:45
06/01/20
08:45
DDS

Dillard's

$30.00 /

-0.37 (-1.22%)

, TLRD

Tailored Brands

$1.29 /

+ (+0.00%)

, CATS

Catasys

$19.49 /

+0.23 (+1.19%)

, DNR

Denbury Resources

$0.24 /

-0.0076 (-3.13%)

, SSYS

Stratasys

$17.91 /

-0.21 (-1.16%)

, GSX

GSX Techedu

$31.37 /

+1.515 (+5.07%)

, TUR

iShares MSCI Turkey Index

$21.66 /

+0.11 (+0.51%)

, APRN

Blue Apron

$9.37 /

+0.69 (+7.95%)

, IVR

Invesco Mortgage

$2.77 /

-0.07 (-2.46%)

, ACB

Aurora Cannabis

$14.09 /

-1.29 (-8.39%)

Latest data shows the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DDS Dillard's
$30.00 /

-0.37 (-1.22%)

TLRD Tailored Brands
$1.29 /

+ (+0.00%)

CATS Catasys
$19.49 /

+0.23 (+1.19%)

DNR Denbury Resources
$0.24 /

-0.0076 (-3.13%)

SSYS Stratasys
$17.91 /

-0.21 (-1.16%)

GSX GSX Techedu
$31.37 /

+1.515 (+5.07%)

APRN Blue Apron
$9.37 /

+0.69 (+7.95%)

IVR Invesco Mortgage
$2.77 /

-0.07 (-2.46%)

ACB Aurora Cannabis
$14.09 /

-1.29 (-8.39%)

DDS Dillard's
$30.00 /

-0.37 (-1.22%)

05/15/20 JPMorgan
Dillard's price target lowered to $23 from $32 at JPMorgan
05/07/20 Deutsche Bank
Dillard's price target lowered to $18 from $36 at Deutsche Bank
04/30/20 Wedbush
Dillard's price target lowered to $25 from $63 at Wedbush
01/24/20 Odeon Capital
Dillard's initiated with a Sell at Odeon Capital
TLRD Tailored Brands
$1.29 /

+ (+0.00%)

03/19/20 Deutsche Bank
Tailored Brands price target lowered to $1 from $4 at Deutsche Bank
06/13/19 B. Riley FBR
Tailored Brands price target lowered to $7 from $10 at B. Riley FBR
CATS Catasys
$19.49 /

+0.23 (+1.19%)

05/06/20 RBC Capital
Short report targeting Catasys 'doesn't break new ground,' says RBC Capital
04/20/20 RBC Capital
Catasys initiated with an Outperform at RBC Capital
04/20/20 Canaccord
Catasys price target raised to $35 from $26 at Canaccord
03/16/20 Canaccord
Canaccord says three focus names names have limited COVID-19 impact
DNR Denbury Resources
$0.24 /

-0.0076 (-3.13%)

03/31/20 Stifel
Denbury Resources downgraded to Sell from Hold at Stifel
03/20/20 Stephens
Stephens upgrades Hess, downgrades 11 others in E&P following oil's melt down
03/20/20 Stephens
Denbury Resources downgraded to Underweight from Equal Weight at Stephens
06/06/19 Imperial Capital
Denbury Resources price target lowered to $2 from $3 at Imperial Capital
SSYS Stratasys
$17.91 /

-0.21 (-1.16%)

05/21/20 JPMorgan
Stratasys upgraded to Neutral with $19 price target at JPMorgan
05/21/20 JPMorgan
Stratasys upgraded to Neutral from Underweight at JPMorgan
04/27/20 Piper Sandler
Stratasys Q1 results likely to be below plan, says Piper Sandler
04/06/20 JPMorgan
Stratasys, 3D Systems losing share amid new entrants, says JPMorgan
GSX GSX Techedu
$31.37 /

+1.515 (+5.07%)

05/11/20 Barclays
GSX Techedu offered comprehensive rebuttal to short sellers, says Barclays
05/11/20 Nomura Instinet
GSX Techedu price target raised to $40 from $35 at Nomura Instinet
05/07/20 CLSA
GSX Techedu downgraded to Sell from Outperform at CLSA
05/07/20 Citi
GSX Techedu share buyback to offer support, says Citi
TUR iShares MSCI Turkey Index
$21.66 /

+0.11 (+0.51%)

APRN Blue Apron
$9.37 /

+0.69 (+7.95%)

02/20/20 SunTrust
Blue Apron price target lowered to $5 from $8 at SunTrust
02/19/20 Canaccord
Blue Apron price target lowered to $5 from $7 at Canaccord
02/19/20 SunTrust
SunTrust cuts Blue Apron target to $5, views sale as likely review outcome
10/31/19 SunTrust
Blue Apron price target cut to $8 from $10 at SunTrust
IVR Invesco Mortgage
$2.77 /

-0.07 (-2.46%)

05/27/20 Barclays
Invesco Mortgage downgraded to Underweight on book value erosion at Barclays
05/27/20 Barclays
Invesco Mortgage downgraded to Underweight from Equal Weight at Barclays
05/26/20 Credit Suisse
Invesco Mortgage downgraded to Underperform from Neutral at Credit Suisse
04/08/20 JonesTrading
Invesco Mortgage downgraded to Hold from Buy at JonesTrading
ACB Aurora Cannabis
$14.09 /

-1.29 (-8.39%)

05/22/20 CIBC
Aurora Cannabis price target raised to C$24 from C$14 at CIBC
05/22/20
Fly Intel: Top five analyst downgrades
05/22/20 Jefferies
Aurora Cannabis downgraded to Underperform from Hold at Jefferies
05/21/20 Stifel
Stifel keeps Sell rating on Aurora, calls Reliva deal a 'small but good step'
DDS Dillard's
$30.00 /

-0.37 (-1.22%)

TLRD Tailored Brands
$1.29 /

+ (+0.00%)

CATS Catasys
$19.49 /

+0.23 (+1.19%)

DNR Denbury Resources
$0.24 /

-0.0076 (-3.13%)

SSYS Stratasys
$17.91 /

-0.21 (-1.16%)

GSX GSX Techedu
$31.37 /

+1.515 (+5.07%)

APRN Blue Apron
$9.37 /

+0.69 (+7.95%)

IVR Invesco Mortgage
$2.77 /

-0.07 (-2.46%)

ACB Aurora Cannabis
$14.09 /

-1.29 (-8.39%)

DNR Denbury Resources
$0.24 /

-0.0076 (-3.13%)

GSX GSX Techedu
$31.37 /

+1.515 (+5.07%)

APRN Blue Apron
$9.37 /

+0.69 (+7.95%)

ACB Aurora Cannabis
$14.09 /

-1.29 (-8.39%)

DDS Dillard's
$30.00 /

-0.37 (-1.22%)

TLRD Tailored Brands
$1.29 /

+ (+0.00%)

SSYS Stratasys
$17.91 /

-0.21 (-1.16%)

GSX GSX Techedu
$31.37 /

+1.515 (+5.07%)

APRN Blue Apron
$9.37 /

+0.69 (+7.95%)

IVR Invesco Mortgage
$2.77 /

-0.07 (-2.46%)

ACB Aurora Cannabis
$14.09 /

-1.29 (-8.39%)

TLRD Tailored Brands
$1.29 /

+ (+0.00%)

CATS Catasys
$19.49 /

+0.23 (+1.19%)

DNR Denbury Resources
$0.24 /

-0.0076 (-3.13%)

SSYS Stratasys
$17.91 /

-0.21 (-1.16%)

GSX GSX Techedu
$31.37 /

+1.515 (+5.07%)

TUR iShares MSCI Turkey Index
$21.66 /

+0.11 (+0.51%)

APRN Blue Apron
$9.37 /

+0.69 (+7.95%)

IVR Invesco Mortgage
$2.77 /

-0.07 (-2.46%)

ACB Aurora Cannabis
$14.09 /

-1.29 (-8.39%)

Hot Stocks
Gilead announces topline results from Phase 3 SIMPLE trial » 08:44
06/01/20
06/01
08:44
06/01/20
08:44
GILD

Gilead

$77.80 /

+2.43 (+3.22%)

Gilead announced topline…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$77.80 /

+2.43 (+3.22%)

GILD Gilead
$77.80 /

+2.43 (+3.22%)

05/27/20 Raymond James
Raymond James keeps Market Perform on Gilead following Arcus partnership
05/27/20 Wedbush
Arcus Biosciences price target raised to $48 from $40 at Wedbush
05/27/20 Piper Sandler
Piper says partnership more favorable for Gilead than outright Arcus purchase
05/27/20 RBC Capital
Pullback in Gilead stock offers more attractive opportunity, says RBC Capital
GILD Gilead
$77.80 /

+2.43 (+3.22%)

GILD Gilead
$77.80 /

+2.43 (+3.22%)

GILD Gilead
$77.80 /

+2.43 (+3.22%)

GILD Gilead
$77.80 /

+2.43 (+3.22%)

Hot Stocks
Camber Energy, Viking Energy amend merger agreement » 08:44
06/01/20
06/01
08:44
06/01/20
08:44
CEI

Camber Energy

$1.28 /

+0.03 (+2.40%)

Camber Energy and Viking…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CEI Camber Energy
$1.28 /

+0.03 (+2.40%)

Hot Stocks
Rezolute present RZ358 clinical data-validated in PK, glycemic response in HI » 08:43
06/01/20
06/01
08:43
06/01/20
08:43
RZLT

Rezolute

$0.00 /

+ (+0.00%)

Rezolute announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RZLT Rezolute
$0.00 /

+ (+0.00%)

RZLT Rezolute
$0.00 /

+ (+0.00%)

10/09/19 JMP Securities
Rezolute initiated with an Outperform at JMP Securities
09/09/19 Canaccord
Rezolute initiated with a Buy at Canaccord
Hot Stocks
Ferroglobe announces 'unqualified' audit opinion including going concern » 08:41
06/01/20
06/01
08:41
06/01/20
08:41
GSM

Ferroglobe

$0.71 /

-0.0441 (-5.84%)

Ferroglobe filed its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GSM Ferroglobe
$0.71 /

-0.0441 (-5.84%)

GSM Ferroglobe
$0.71 /

-0.0441 (-5.84%)

09/16/19 Stifel
Ferroglobe downgraded to Hold from Buy at Stifel
GSM Ferroglobe
$0.71 /

-0.0441 (-5.84%)

Hot Stocks
Xperi, TiVo announce completion of merger, TIVO no longer listed for trading » 08:41
06/01/20
06/01
08:41
06/01/20
08:41
XPER

Xperi

$13.76 /

-0.36 (-2.55%)

, TIVO

TiVo

$6.21 /

-0.21 (-3.27%)

Xperi Holding announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XPER Xperi
$13.76 /

-0.36 (-2.55%)

TIVO TiVo
$6.21 /

-0.21 (-3.27%)

XPER Xperi
$13.76 /

-0.36 (-2.55%)

08:21 Today B. Riley FBR
Xperi price target raised to $35 from $31 at B. Riley FBR
05/07/20 Craig-Hallum
Xperi price target lowered to $20 from $25 at Craig-Hallum
02/24/20 B. Riley FBR
Xperi worth 55% more than Metis takeover proposal, says B. Riley FBR
02/19/20 B. Riley FBR
TiVo price target raised to $21 from $19 at B. Riley FBR
TIVO TiVo
$6.21 /

-0.21 (-3.27%)

08:21 Today B. Riley FBR
Xperi price target raised to $35 from $31 at B. Riley FBR
03/12/20 B. Riley FBR
TiVo attractive in uncertain COVID-19 environment, says B. Riley FBR
03/03/20 B. Riley FBR
InterDigital 2020 outlook not at risk from coronavirus, says B. Riley FBR
02/24/20 B. Riley FBR
Xperi worth 55% more than Metis takeover proposal, says B. Riley FBR
XPER Xperi
$13.76 /

-0.36 (-2.55%)

TIVO TiVo
$6.21 /

-0.21 (-3.27%)

TIVO TiVo
$6.21 /

-0.21 (-3.27%)

XPER Xperi
$13.76 /

-0.36 (-2.55%)

TIVO TiVo
$6.21 /

-0.21 (-3.27%)

Hot Stocks
Resideo names Phillip Theodore as Chief Transformation Officer » 08:41
06/01/20
06/01
08:41
06/01/20
08:41
REZI

Resideo

$7.08 /

+0.52 (+7.93%)

Resideo Technologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REZI Resideo
$7.08 /

+0.52 (+7.93%)

REZI Resideo
$7.08 /

+0.52 (+7.93%)

04/28/20 Imperial Capital
Resideo downgraded to In-Line from Outperform at Imperial Capital
04/03/20
Fly Intel: Top five analyst initiations
04/03/20 Roth Capital
Resideo initiated with a Neutral at Roth Capital
02/28/20 Imperial Capital
Resideo upgraded to Outperform from In-Line at Imperial Capital
REZI Resideo
$7.08 /

+0.52 (+7.93%)

Hot Stocks
Equity Residential provides quarter-to-date statistics for Q2 » 08:40
06/01/20
06/01
08:40
06/01/20
08:40
EQR

Equity Residential

$60.57 /

-0.3 (-0.49%)

Equity Residential…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EQR Equity Residential
$60.57 /

-0.3 (-0.49%)

EQR Equity Residential
$60.57 /

-0.3 (-0.49%)

05/18/20 BofA
BofA upgrades Camden Property to Buy, cuts Equity Residential, Aimco
05/18/20 BofA
Equity Residential downgraded to Neutral from Buy at BofA
05/10/20 Evercore ISI
Equity Residential upgraded to In Line from Underperform at Evercore ISI
04/24/20 Piper Sandler
Equity Residential downgraded to Underweight from Neutral at Piper Sandler
EQR Equity Residential
$60.57 /

-0.3 (-0.49%)

EQR Equity Residential
$60.57 /

-0.3 (-0.49%)

Recommendations
Surmodics price target raised to $76 from $50 at Lake Street » 08:40
06/01/20
06/01
08:40
06/01/20
08:40
SRDX

Surmodics

$37.01 /

-1.42 (-3.70%)

Lake Street analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRDX Surmodics
$37.01 /

-1.42 (-3.70%)

02/06/20 Barrington
Surmodics price target lowered to $56 from $62 at Barrington
02/06/20 Lake Street
Surmodics upgraded to Buy from Hold at Lake Street
12/11/19 Needham
Surmodics downgraded to Hold from Buy at Needham
11/01/19 Lake Street
Surmodics downgraded to Hold from Buy at Lake Street
SRDX Surmodics
$37.01 /

-1.42 (-3.70%)

Hot Stocks
Resverlogix plans COVID-19 trial program launch » 08:40
06/01/20
06/01
08:40
06/01/20
08:40

Resverlogix announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
ANI Pharmaceuticals provides update regarding Cortrophin Gel sNDA filing » 08:39
06/01/20
06/01
08:39
06/01/20
08:39
ANIP

ANI Pharmaceuticals

$31.15 /

-0.71 (-2.23%)

ANI Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANIP ANI Pharmaceuticals
$31.15 /

-0.71 (-2.23%)

ANIP ANI Pharmaceuticals
$31.15 /

-0.71 (-2.23%)

05/08/20 Raymond James
ANI Pharmaceuticals price target lowered to $49 from $65 at Raymond James
05/07/20 Cantor Fitzgerald
Cantor downgrades ANI Pharmaceuticals to Neutral on near-term uncertainty
05/07/20 Cantor Fitzgerald
ANI Pharmaceuticals downgraded to Neutral from Overweight at Cantor Fitzgerald
09/11/19 Guggenheim
ANI Pharmaceuticals initiated with a Buy at Guggenheim
ANIP ANI Pharmaceuticals
$31.15 /

-0.71 (-2.23%)

Hot Stocks
SurveyMonkey announces return to work offering for enterprise customers » 08:38
06/01/20
06/01
08:38
06/01/20
08:38
SVMK

SurveyMonkey

$20.15 /

+0.58 (+2.96%)

SurveyMonkey announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SVMK SurveyMonkey
$20.15 /

+0.58 (+2.96%)

SVMK SurveyMonkey
$20.15 /

+0.58 (+2.96%)

05/18/20 Wells Fargo
Wells upgrades SurveyMonkey to Overweight on resilience, increasing relevance
05/18/20 Wells Fargo
SurveyMonkey upgraded to Overweight from Equal Weight at Wells Fargo
05/14/20 Needham
SurveyMonkey initiated with a Buy at Needham
01/17/20 Wells Fargo
SurveyMonkey price target raised to $21 from $18 at Wells Fargo
SVMK SurveyMonkey
$20.15 /

+0.58 (+2.96%)

SVMK SurveyMonkey
$20.15 /

+0.58 (+2.96%)

SVMK SurveyMonkey
$20.15 /

+0.58 (+2.96%)

Hot Stocks
Iterum Therapeutics evaluating corporate, strategic, financial alternatives » 08:37
06/01/20
06/01
08:37
06/01/20
08:37
ITRM

Iterum Therapeutics

$4.23 /

-0.14 (-3.20%)

Based on the trial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITRM Iterum Therapeutics
$4.23 /

-0.14 (-3.20%)

ITRM Iterum Therapeutics
$4.23 /

-0.14 (-3.20%)

01/21/20 Gabelli
Iterum Therapeutics downgraded to Sell from Buy at Gabelli
12/11/19 RBC Capital
Iterum Therapeutics price target lowered to $10 from $14 at RBC Capital
12/11/19 SVB Leerink
Iterum Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
06/21/19 H.C. Wainwright
Iterum Therapeutics initiated with a Buy at H.C. Wainwright
ITRM Iterum Therapeutics
$4.23 /

-0.14 (-3.20%)

Hot Stocks
Iterum says Phase 3 trial of sulopenem did not meet primary endpoint » 08:37
06/01/20
06/01
08:37
06/01/20
08:37
ITRM

Iterum Therapeutics

$4.23 /

-0.14 (-3.20%)

Iterum Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITRM Iterum Therapeutics
$4.23 /

-0.14 (-3.20%)

ITRM Iterum Therapeutics
$4.23 /

-0.14 (-3.20%)

01/21/20 Gabelli
Iterum Therapeutics downgraded to Sell from Buy at Gabelli
12/11/19 RBC Capital
Iterum Therapeutics price target lowered to $10 from $14 at RBC Capital
12/11/19 SVB Leerink
Iterum Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
06/21/19 H.C. Wainwright
Iterum Therapeutics initiated with a Buy at H.C. Wainwright
ITRM Iterum Therapeutics
$4.23 /

-0.14 (-3.20%)

Recommendations
Canopy Growth price target lowered to C$24 from C$30 at Alliance Global Partners » 08:37
06/01/20
06/01
08:37
06/01/20
08:37
CGC

Canopy Growth

$17.36 /

-4.37 (-20.11%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CGC Canopy Growth
$17.36 /

-4.37 (-20.11%)

CGC Canopy Growth
$17.36 /

-4.37 (-20.11%)

06:30 Today BMO Capital
Canopy Growth downgraded to Market Perform from Outperform at BMO Capital
06:26 Today CIBC
Canopy Growth downgraded to Neutral from Outperformer at CIBC
05:37 Today Stifel
Stifel double downgrades Canopy Growth to Sell on 'course correction'
05:30 Today CIBC
Canopy Growth downgraded to Neutral from Outperformer at CIBC
CGC Canopy Growth
$17.36 /

-4.37 (-20.11%)

CGC Canopy Growth
$17.36 /

-4.37 (-20.11%)

CGC Canopy Growth
$17.36 /

-4.37 (-20.11%)

CGC Canopy Growth
$17.36 /

-4.37 (-20.11%)

Hot Stocks
Anixa Biosciences, OntoChem synthesize four potential COVID-19 compounds » 08:37
06/01/20
06/01
08:37
06/01/20
08:37
ANIX

Anixa Biosciences

$2.29 /

-0.005 (-0.22%)

Anixa Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANIX Anixa Biosciences
$2.29 /

-0.005 (-0.22%)

ANIX Anixa Biosciences
$2.29 /

-0.005 (-0.22%)

12/30/19 B. Riley FBR
Anixa Biosciences price target lowered to $8 from $11.25 at B. Riley FBR
Recommendations
Burlington Stores price target raised to $250 from $184 at RBC Capital » 08:36
06/01/20
06/01
08:36
06/01/20
08:36
BURL

Burlington Stores

$209.70 /

-3.735 (-1.75%)

RBC Capital analyst Kate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BURL Burlington Stores
$209.70 /

-3.735 (-1.75%)

BURL Burlington Stores
$209.70 /

-3.735 (-1.75%)

05/29/20 DA Davidson
Burlington Stores price target raised to $250 from $215 at DA Davidson
05/29/20 Loop Capital
Burlington Stores price target lowered to $250 from $265 at Loop Capital
05/29/20 Citi
Burlington Stores price target raised to $250 from $205 at Citi
05/11/20 Nomura Instinet
Burlington Stores price target raised to $190 from $170 at Nomura Instinet
BURL Burlington Stores
$209.70 /

-3.735 (-1.75%)

BURL Burlington Stores
$209.70 /

-3.735 (-1.75%)

BURL Burlington Stores
$209.70 /

-3.735 (-1.75%)

Hot Stocks
Eldorado Resorts to open 3 Missouri casinos, 2 Iowa casinos » 08:36
06/01/20
06/01
08:36
06/01/20
08:36
ERI

Eldorado Resorts

$35.52 /

+0.79 (+2.27%)

Eldorado Resorts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ERI Eldorado Resorts
$35.52 /

+0.79 (+2.27%)

ERI Eldorado Resorts
$35.52 /

+0.79 (+2.27%)

05/12/20 Deutsche Bank
Eldorado Resorts price target lowered to $28 from $68 at Deutsche Bank
05/12/20 Jefferies
Eldorado Resorts price target raised to $38 from $29 at Jefferies
04/17/20 SunTrust
Caesars, Twin River Worldwide upgraded to Buy from Hold at SunTrust
04/06/20 Jefferies
Eldorado has 'considerable upside' from Caesars merger, says Jefferies
ERI Eldorado Resorts
$35.52 /

+0.79 (+2.27%)

ERI Eldorado Resorts
$35.52 /

+0.79 (+2.27%)

ERI Eldorado Resorts
$35.52 /

+0.79 (+2.27%)

ERI Eldorado Resorts
$35.52 /

+0.79 (+2.27%)

Hot Stocks
EIB, Voxeljet expand partnership to bring 3D printing into series production » 08:36
06/01/20
06/01
08:36
06/01/20
08:36
VJET

Voxeljet

$1.12 /

-0.02 (-1.75%)

Voxeljet announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VJET Voxeljet
$1.12 /

-0.02 (-1.75%)

VJET Voxeljet
$1.12 /

-0.02 (-1.75%)

10/29/19 Piper Jaffray
Piper 3D printing survey brings better feedback in Q3
08/18/19 Piper Jaffray
Voxeljet price target lowered to $3 from $4.75 at Piper Jaffray
Hot Stocks
Revance, Mylan to advance development program for Botox biosimilar » 08:35
06/01/20
06/01
08:35
06/01/20
08:35
RVNC

Revance

$20.88 /

-0.46 (-2.16%)

, MYL

Mylan

$17.10 /

-0.15 (-0.87%)

Revance Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RVNC Revance
$20.88 /

-0.46 (-2.16%)

MYL Mylan
$17.10 /

-0.15 (-0.87%)

RVNC Revance
$20.88 /

-0.46 (-2.16%)

03/27/20 H.C. Wainwright
Revance price target lowered to $24 from $28 at H.C. Wainwright
03/23/20
Fly Intel: Top five analyst downgrades
03/22/20 Goldman Sachs
Revance downgraded to Neutral from Buy at Goldman Sachs
02/26/20 H.C. Wainwright
Revance price target raised to $28 from $23 at H.C. Wainwright
MYL Mylan
$17.10 /

-0.15 (-0.87%)

03/25/20 Cantor Fitzgerald
Few concerns weighing on Mylan shares today, says Cantor Fitzgerald
02/06/20 BMO Capital
Biogen price target raised to $317 from $297 at BMO Capital
02/05/20 Baird
Biogen price target raised to $290 from $250 at Baird
02/05/20 Mizuho
Biogen's Tecfidera win worth $15-$30 per share to DCF, Mizuho says
RVNC Revance
$20.88 /

-0.46 (-2.16%)

MYL Mylan
$17.10 /

-0.15 (-0.87%)

MYL Mylan
$17.10 /

-0.15 (-0.87%)

MYL Mylan
$17.10 /

-0.15 (-0.87%)

MYL Mylan
$17.10 /

-0.15 (-0.87%)

Hot Stocks
Twin River Worldwide to open nearly entire portfolio of operating casinos » 08:35
06/01/20
06/01
08:35
06/01/20
08:35
TRWH

Twin River Worldwide

$20.95 /

+0.24 (+1.16%)

Twin River Worldwide…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRWH Twin River Worldwide
$20.95 /

+0.24 (+1.16%)

TRWH Twin River Worldwide
$20.95 /

+0.24 (+1.16%)

05/29/20 SunTrust
Twin River Worldwide price target raised to $25 from $20 at SunTrust
04/17/20 SunTrust
Caesars, Twin River Worldwide upgraded to Buy from Hold at SunTrust
04/17/20 SunTrust
Twin River Worldwide upgraded to Buy from Hold at SunTrust
02/12/20 SunTrust
Twin River Worldwide price target raised to $31 from $26 at SunTrust
TRWH Twin River Worldwide
$20.95 /

+0.24 (+1.16%)

General news
Oil Action: July WTI crude » 08:35
06/01/20
06/01
08:35
06/01/20
08:35

Oil Action: July WTI…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
WNS Holdings elevated to Fresh Pick at Baird » 08:34
06/01/20
06/01
08:34
06/01/20
08:34
WNS

WNS Holdings

$48.37 /

+0.13 (+0.27%)

Baird analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WNS WNS Holdings
$48.37 /

+0.13 (+0.27%)

WNS WNS Holdings
$48.37 /

+0.13 (+0.27%)

04/24/20 Deutsche Bank
WNS Holdings price target lowered to $56 from $81 at Deutsche Bank
04/23/20 Needham
WNS Holdings downgraded to Buy from Strong Buy at Needham
04/21/20 Cowen
WNS Holdings price target lowered to $57 from $77 at Cowen
04/17/20 Wells Fargo
WNS Holdings downgraded to Equal Weight from Overweight at Wells Fargo
WNS WNS Holdings
$48.37 /

+0.13 (+0.27%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.